Abstract

Background: Topical antiseptic and antibiotic agents have been used for the prevention of surgical site infections since Joseph Lister’s original research on this subject. Although these agents are used extensively in clinical practice, evidence to support the use of topical antimicrobial agents remains limited.

Patients and Methods: The world literature on the use of antiseptic and antibiotic agents was evaluated to determine the current status of evidence to support the use of topical antimicrobial agents in the prevention of surgical site infections.

Results: Although several techniques of using topical antibiotic solutions, powders, antibiotic gauzes, and beads have some evidence for validation, there are equal numbers of reports that have failed to show benefit. There is little evidence to support the use of antiseptic solutions in the prevention of infections at the surgical site.

Conclusions: Additional clinical trials are necessary to provide evidence to support any of the methods for using topical antimicrobial agents to present surgical site infections. Dilute antiseptic agents should be considered in future trials when antimicrobial activity can be identified without local toxicity.

Abstract

Background: Mechanical bowel preparation continues to be a controversial subject for the pre-operative management of patients undergoing elective colon resection.

Methods: The English literature on bowel preparation was searched to identify pertinent publications.

Results: The published literature over the past 80 y confirms that mechanical bowel preparation alone does not reduce surgical site infections. However, the use of appropriate oral antibiotics following mechanical bowel preparation with pre-operative systemic antibiotics reduces rates of surgical site infections and anastomotic leaks when compared with systemic antibiotics alone.

Conclusions: Mechanical bowel preparation with pre-operative oral antibiotics and pre-operative systemic antibiotics are the standard of care for elective colon surgery. Refinement in methods of bowel preparation needs additional clinical investigations to further enhance outcomes.

Abstract

Background: The Surgical Infection Society (SIS) through its foundation (FDTN) confers awards to individuals who demonstrate interest in researching infection in the surgical setting. We sought to characterize the research output from prior award recipients and determine the impact of these awards on the individual and the SIS.

Methods: The SIS website was queried for the names of all past award recipients. A MEDLINE search of the recipients was performed. Total number of publications and publications in the society’s journal, Surgical Infections (SI), were identified. Gender and leadership positions within SIS were determined. Meeting attendance and participation were assessed. Donations by scholarship recipient to the FDTN were evaluated.

Results: Between 1984 and 2012, 116 individuals received an SIS award or scholarship. Of these, 72% were male. There were 101 scholarships awarded, totaling nearly $3 million. Of the 19 new Junior Faculty Scholarships awarded, four were to consecutive recipients (CR). There were 11 clinical evaluative award scholarships awarded, three to CR. There were 100 Resident/Fellow scholarships awarded, and of these, 22 were awarded to CR. Past recipients had multiple publications (median total publications = 27; interquartile range (IQR): Nine to 62) and published multiple papers on the topic for which they received an award (median two; IQR: Zero to four). Recipients did not publish in SI (median SI publications = zero; IQR: Zero to one). There was no substantial difference in the number of publications by gender. Multiple awards (MA) were conferred to 26 (22%) individuals. Six (5.1%) assumed an executive position within SIS, two (1.7%) became SIS president. Those who received MA were more likely to serve as an officer than those who only received one award (15% vs. 2%, p = 0.02).

Conclusions: Scholarships have a large benefit for individual recipients; however, the benefit to the society remains harder to quantify.

Abstract

Background: Gentamicin is used commonly as an empiric antibiotic prior to culture evidence in the treatment of ventilator-associated pneumonia (VAP) in surgical patients.

Methods: The published literature on the use of gentamicin for empiric therapy in VAP was reviewed and in combination with the author’s personal experience, an evaluation has been made about the indications for the use of this antibiotic in VAP.

Results: Empiric gentamicin use appears to benefit less than 1% of patients in the treatment of presumptive VAP. The problematic pharmacokinetics of gentamicin use in this patient population combined with potential toxicity from the drug can be observed to yield greater risks than benefits in this clinical situation when published evidence is reviewed.

Conclusion: There is no definitive evidence to support empiric use of gentamicin in the treatment of VAP when evaluated on a cost-effective basis.

Abstract

Management of Clostridium difficile infections is usually accomplished through appropriate antimicrobial therapy. However, in patients that do not respond to this therapy, rapid and potentially lethal progressive organ dysfunction care occurs. Although supportive care and continued antimicrobial therapy is important, surgical therapy is critical to eradication of the inflammatory process and reversal of the dysregulated immunity associated with severe C. difficile infections. In the following paper, the role of colectomy is reviewed